SIMAP

SIMAP will develop a simulation model of the cancer related MAP-kinase pathway, integrating and analyzing data from various types of resources, which may assist in the development of better cancer treatment.

The completion of the human genome gave hope for a new age of medical understanding, but 4-5 years later costs of drug development are still rising and the success rate has not improved. Drugs that have already hit the market are found to have major side effects not perceived in the past and are often given to patients without discrimination on their likeliness to respond.

Large scale methodologies that thrive in recent years, allowed the industry and academia to gather more information on RNAs and proteins. However, the understanding of the molecular and cellular processes is still lacking, not to mention the connection to the clinical outcome. In order to fully use this data, a comprehensive integration and modelling effort is needed. A systematic rational hypothesis-driven research approach connecting all those levels of information is a much needed computational tool. This is the main goal of SIMAP project.

The ultimate goal of SIMAP is to develop a comprehensive simulation biochemical model of EGFRMAP kinase pathway in connection to cancer clinical information. SIMAP will:

  • Incorporate low-level biochemical modelling of individual molecules;
  • Simulate the behaviour of the pathway;
  • Add genomic and proteomic data;
  • Incorporate individual patients’ responses; and
  • Analyze sub population of responses in the context of the biochemical behaviour and genotype data

For further information, please visit:
http://www.simap-project.org

Project co-ordinator:
Compugen Ltd.

Partners:

  • Aureus Pharma, (FR)
  • Compugen Ltd., (IL)
  • Consejo Superior de Investigaciones Científicas, (ES)
  • Halevi Dweck & Co.Arttic Israel Company Ltd., (IL)
  • Fundacio Institut De Recerca De L'Hospital Universitari Vall D'Hebron, (ES)
  • Fondazione IRCCS Istituto Nazionale Dei Tumori, (IT)
  • The Max-Planck Institute for Infection Biology, (DE)
  • The University of Glasgow, (UK)
  • The Weizmann Institute of Science, (IL)

Timetable: from 01/06 – to 12/08

Total cost: € 4.464.201

EC funding: € 3.126.662

Instrument: STREP

Project Identifier: IST-2004-027265

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

Researchers Apply Computing Power to Tra…

Princeton researchers have developed a new computational method that increases the ability to track the spread of cancer cells from one part of the body to another. This migration of...

Philips Powers First Tele-Intensive Care…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Japan-based Showa University announced the launch of Japan's first telemedicine intensive care (eICU) program at Showa University...

Open Call SC1-DTH-10-2019-2020: Digital …

Digital solutions supporting a continuum of care across a range of health and care services can relieve the pressure on governments to provide more cost-effective health and care systems by...

AI and Radar Technologies could Help Dia…

People with diabetes could be able to monitor their blood sugar without drawing blood using a system now being developed at the University of Waterloo. In a recent study, researchers...

Bad Habits that Lead to Cancer, Chronic …

Does this sound like someone you know? He or she spends too much time in front of screens, gets little exercise and eats a diet high in fat and low...

Private Healthcare Data to be Captured b…

An initiative has been launched to ensure private healthcare data is recorded in the same way as NHS data in England, with the aim of improving consistency across the system...

Research Finds Three Major Failings in s…

In the scramble to bring successful apps for the diagnosis of skin cancer to market there is a concern that a lack of testing is risking public safety, according to...

New Tissue-Imaging Technology could Enab…

A new microscope system can image living tissue in real time and in molecular detail, without any chemicals or dyes, report researchers at the University of Illinois. The system uses...

New Technology Helps to Improve Treatmen…

A new web-based "feedback" technology which allows therapists to accurately monitor how patients with depression are coping has been found to reduce the probability of deterioration during psychological treatment by...

Rapid Zika Detection Test Uses Smartphon…

The Zika virus, which continues to cause microcephaly and other neurological complications in infants whose mothers were infected during pregnancy, remains a public health concern. Investigators from Brigham and Women's...

AAL Market and Investment Report

The AAL Market and Investment Report was commissioned by the Ambient Assisted Living Association and aims to provide a consolidated view of the existing market and investment information in Europe...